Mid-old cells are a potential target for anti-aging interventions in the elderly.

Area of Science:

• Cellular biology
• Gerontology
• Tissue engineering

Background:

• Aging is linked to senescent cell accumulation.
• Organ stroma, composed of fibroblasts and smooth muscle cells, plays a critical role in tissue health.
• The functional state of stromal cells in the elderly requires further investigation.

Purpose of the Study:

• To identify and characterize novel cell populations in aged organ stroma.
• To investigate the molecular mechanisms underlying age-related tissue dysfunction.
• To explore potential therapeutic interventions for ameliorating aging effects.

Main Methods:

• Cellular characterization of fibroblasts and smooth muscle cells from elderly tissues.
• Gene expression analysis (IL1B, SAA1, SLIT2, CXCL12) in identified cell populations.
• Assessment of the impact of SAA1 on the tissue microenvironment and epithelial cell function.
• Investigating the effect of SLIT2 on mid-old cell function and the microenvironment.

Main Results:

• A novel cell subset, termed "mid-old status" cells, was identified in elderly organ stroma.
• Mid-old cells exhibit upregulated pro-inflammatory genes (IL1B, SAA1) and downregulated anti-inflammatory genes (SLIT2, CXCL12).
• SAA1 promotes an inflammatory microenvironment by upregulating MMP9, impairing epithelial cell stability and function.
• SLIT2, a protein from young cells, reversed mid-old cell dysfunction and microenvironmental changes.

Conclusions:

• Mid-old status cells contribute to age-related tissue dysfunction through inflammatory signaling.
• Targeting these mid-old cells or their associated pathways offers a potential strategy for combating aging.
• Functional reversion of mid-old cells using factors like SLIT2 may prevent or alleviate age-related tissue decline.